Eli Lilly’s Obesity Drugs Drive Massive Revenue Growth
- Posted on August 5, 2026
- By Forbes
- 0 Views
- 1 min read
In brief
Generating AI summary…
Eli Lilly’s Obesity Drugs Drive Massive Revenue Growth
In this week’s edition of InnovationRx, we look at Lilly’s 2Q earnings, a cannabis-derived drug for PTSD, Apnimed’s IPO and more
